AbbatiaLabs

AbbatiaLabs is a Swiss startup that develops an innovative dosing and primary packaging solution for oral solid drugs to enable precise bodyweight-based titration. The company is headquartered in Lausanne, Switzerland.

Here are key aspects of the company:

• Products & Services: POWDOSE is a patented, patient-centric device designed as ready-to-use primary packaging that allows users to perform only two steps to obtain the exact amount of drug needed for personalized dosing.
• Industries: The solution targets therapeutic areas requiring precise dose adjustments, specifically benefiting vulnerable populations such as children and the elderly through bodyweight-based or condition-specific formulations.
• Innovation: AbbatiaLabs offers a platform applicable to multiparticulates, minitablets, or granulate-based medicines that maintains drugs in dry solid form until administration to improve stability and ensure reliable access.
• Sustainability: The device features a low carbon footprint by being constructed from a limited number of environmentally friendly sustainable polymers while ensuring extended stability through an encapsulated container design with high moisture protection.

AbbatiaLabs aims to set a new global standard for oral drug delivery by combining precise dosing simplicity with value-added medicine differentiation for pharmaceutical partners.